GTC Biotherapeutics (fka GTCB)

[DewDiligence]

Current Insider Shareholdings and Options

[Includes transactions through 3/14/08. Other than the options
granted with an exercise price of 0.63 on 3/7/08 (#msg-27509339),
all options have an exercise price greater than 1.00.]

 
 	 
 Executive Officers  
 Geoffrey Cox, CEO          452K shares   991K options 
 John Green, CFO            116K shares   414K options 
 Harry Meade, SVP Research  157K shares   383K options 
 Greg Liposky, SVP Oprtns    83K shares   371K options 
 Dan Woloshen, Gen. Counsel 100K shares   287K options 
 Dick Scotland, SVP Regltry  98K shares  *267K options 
 -- 
 Six executive officers   1,006K shares 2,713K options

 
 Non-executive directors  
 Robert Baldridge             5K shares    75K options 
 Kenneth Bauer                 0 shares    38K options 
 Christian Béchon            18K shares    15k options 
 Francis Bullock             11K shares    74K options 
 James Geraghty              88K shares   163K options 
 Michael Landine               0 shares    38K options 
 Pamela McNamara              9K shares    53K options 
 Marvin Miller                8K shares    53K options 
 Alan Tuck                   14K shares    51K options 
 Mary Ann Gray               11K shares    15K options 
 -- 
 Ten non-executive directrs 164K shares   575K options

 
 All officers/directors   1,170K shares 3,288K options

*Because Scotland’s detailed options holdings are not shown in GTC’s DEF14a filings, his number of options shown above is an estimate.